Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-05-01
著者
-
Sadagopan Nalini
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development
-
Sadagopan Nalini
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
Cohen Lucinda
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
SMITH Danielle
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global R&D
-
ZIENTEK Michael
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global R&D
-
REDDY Anita
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global R&D
-
Reddy Anita
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
Zientek Michael
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
Smith Danielle
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
関連論文
- Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3',5'-monophosphate (cGMP) in clinical applications : A comparison with a EIA method
- Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery